Plasma p-Tau217 and p-Tau181 levels in Well-Controlled versus Drug-Resistant focal epilepsy
Epilepsy & Behavior · 2026
DOI: 10.1016/j.yebeh.2025.110855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026. Verfasst von Sabina Iqbal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Brigham, Department of Neurology, Harvard Medical School, MA, USA. Hauptthemen laut MEDLINE: tau Proteins, Drug Resistant Epilepsy, Epilepsies, Partial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Massachusetts General Brigham, Department of Neurology, Harvard Medical School, MA, USA.
- Massachusetts General Brigham, Department of Neurology, Harvard Medical School, MA, USA. Electronic address: rsarkis@bwh.harvard.edu.
Zitieren
APA
Iqbal, S., Liu, L., Marshall, G. A., & Sarkis, R. A. (2026). Plasma p-Tau217 and p-Tau181 levels in Well-Controlled versus Drug-Resistant focal epilepsy. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110855
Vancouver
Iqbal S, Liu L, Marshall GA, Sarkis RA. Plasma p-Tau217 and p-Tau181 levels in Well-Controlled versus Drug-Resistant focal epilepsy. Epilepsy & Behavior. 2026. doi:10.1016/j.yebeh.2025.110855
BibTeX
@article{Iqbal2026,
author = {Iqbal, Sabina and Liu, Lei and Marshall, Gad A and Sarkis, Rani A},
title = {Plasma p-Tau217 and p-Tau181 levels in Well-Controlled versus Drug-Resistant focal epilepsy},
journal = {Epilepsy & Behavior},
year = {2026},
doi = {10.1016/j.yebeh.2025.110855}
}
EUVIMED